secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001104659-22-114916
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics completes $3M share repurchase from InvaGen; two directors resign
--------------------------------------------------------------------------------

- Completed $3M repurchase of InvaGen's 100% stake in Avenue, financed by public offering closed Oct 11, 2022.
- Jaideep Gogtay, M.D. and E. Garrett Ingram resigned from Board and all committees effective Oct 31, 2022.
- Resignations not due to any disagreement with Company, its operations, or management.
- All rights granted to InvaGen under 2018 Stockholders Agreement terminated upon share repurchase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/tm2229761d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-114916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer